Brazil authorizes production of active ingredient for AstraZeneca vaccine
- Country:
- Brazil
Brazil's health regulator Anvisa authorized on Friday the government biomedical institute Fiocruz to produce domestically the active ingredient for the AstraZeneca vaccine against COVID-19, according to a statement.
ALSO READ
-
IDB Approves $243m to Bring More Reliable Power to Brazil’s Santa Catarina
-
Brazil’s Tax Reform Gets IDB Loans for State Finances and Public Services
-
São Paulo’s $460M Ferry Overhaul Brings Electric Vessels and New Local Jobs
-
Brazil’s Paraíba Secures $50 Million to Build Stronger Water and Sanitation Services
-
AfDB and Brazil Deepen Mali Cooperation on Food, Jobs and Energy
Google News